Breast Cancer Coverage From Every Angle
Advertisement
Advertisement

Published Medical Literature

Is Hormone Therapy a Risk Factor for Diabetes in Breast Cancer Survivors?
Novel Second-Line Treatment of Aromatase Inhibitor–Resistant Breast Cancer
Genetic Biomarker as Potential Predictor of Platinum Sensitivity in Triple-Negative Breast Cancer
Addition of Veliparib to Standard Neoadjuvant Therapy in Triple-Negative Breast Cancer
Predicting Risk of Breast Cancer: Automated Versus Clinical Assessment of Breast Density
Postmastectomy Radiation Therapy for Locoregional Control of Breast Cancer
CALOR Trial: Adjuvant Chemotherapy for Isolated Locoregional Recurrence of Breast Cancer
Use of Metronomic Chemotherapy in Older Patients With Metastatic Breast Cancer
Bone Turnover Markers in Metastatic Breast Cancer
Combination Therapy Under Study in Treatment-Resistant Breast Cancer
First-Degree Family History and Breast Cancer Risk in Women Older Than Age 65
Androgen Receptor–Targeted Treatment in Triple-Negative Breast Cancer
Distant and Locoregional Recurrence in Stage II or III Breast Cancer
Updated Results on Neratinib in HER2-Positive Breast Cancer
Correlation Between Breast Cancer Mortality and Advances in Screening and Treatment
Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer
Dual HER2 Blockade in Metastatic Breast Cancer
Pertuzumab-Containing Neoadjuvant Regimens in HER2-Positive Breast Cancer
Dual HER2-Targeting Treatments for Postmenopausal Women With Metastatic Breast Cancer
Hormonal Birth Control and Invasive Breast Cancer Risk
Safety Profile of Buparlisib Plus Fulvestrant in Advanced Breast Cancer
Survival Benefit of Intense Dose-Dense Chemotherapy in High-Risk Breast Cancer
Use of Duloxetine for Arthralgias Associated With Breast Cancer Treatment
Letrozole Schedules Compared in Postmenopausal Women With Breast Cancer
Textured Breast Implants and Rare Anaplastic Lymphoma
Type 2 Diabetes and Breast Cancer Subtype in African American Women
Cardiac Effects of Trastuzumab Therapy in Patients With HER2-Positive Breast Cancer
Bacterial Imbalances and Breast Cancer
Initial Therapy With Abemaciclib for Advanced Breast Cancer
Effect of 5 Years’ Endocrine Therapy on Breast Cancer Recurrence
cT1–2N0 Breast Cancer: Less- and More-Invasive Treatment Results
Mortality in Elderly, Mentally Ill Breast Cancer Patients
Physicians’ Views on Radiotherapy for Older Women With Early-Stage Breast Cancer
Neoadjuvant Combination Therapy for HER2-Positive Primary Breast Cancer
HER2-Targeted Therapy and Breast Reconstruction
Soy Foods and Breast Cancer Survival
Surgeon Impact on the Decision to Have Contralateral Prophylactic Mastectomy
Investigational AKT Inhibitor in Triple-Negative Breast Cancer
Neoadjuvant Ado-trastuzumab Emtansine vs. Trastuzumab in Early Breast Cancer
Tamoxifen Metabolite Z-Endoxifen in Metastatic Breast Cancer
Current Treatment Approaches for Triple-Negative Breast Cancer
Response to Immunotherapy in Patients With ‘Claudin-Low’ Breast Tumors
Comparing Trastuzumab-Based Regimens in Older Women With Early-Stage Breast Cancer
Surveillance Mammography for Older Survivors of Breast Cancer
Wound Complications After Breast Reconstruction Procedures
Potential Toxicities Associated With CDK4/6 Inhibitors in Breast Cancer
Using Molecular Signature to Identify Indolent Breast Tumors
Oral Vinorelbine in Patients With Endocrine-Pretreated Breast Cancer
Changes in Histology and Breast Cancer Risk
MONARCH 2: Abemaciclib/Fulvestrant in Hormone Receptor–Positive, HER2-Negative Breast Cancer
Adding Pertuzumab to Trastuzumab and Chemotherapy in HER2-Positive Breast Cancer
Final Survival Data From TH3RESA Trial in Breast Cancer
Final Overall Survival Data From EMILIA Trial
Biologic Differences in Invasive Breast Cancers Among Black and White Patients
OlympiAD Trial: Olaparib in HER2-Negative Metastatic Breast Cancer
Additional Surgery After Initial Lumpectomy
Patient Satisfaction With Breast Reconstruction
More Women Living With Metastatic Breast Cancer
Combining Monoclonal Antibodies in HER2-Positive Breast Cancer
ABC Breast Cancer Trials of Adjuvant Taxane With or Without Anthracycline in HER2-Negative Disease
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Optimizing Adherence to Oral Chemotherapy
Steadily Increasing Breast Cancer Rates in Asian Americans
Study Finds Discrepant Decision-Making for Use of 21-Gene Assay in Women With Early-Stage Breast Cancer
Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
Contralateral Prophylactic Mastectomy Decisions in Patients With Early-Stage Breast Cancer
Identifying Educational Needs of the Multidisciplinary Cancer Team in the Treatment of Metastatic Breast Cancer
A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer
Improved Survival With Higher TIL Values in Advanced HER2-Positive Breast Cancer
A Review of Treatment for Breast Cancer–Related Lymphedema: Paradigms for Clinical Practice
Stereotactic Radiosurgery for Treatment of Brain Metastases


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.